Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 359494, 13 pages
http://dx.doi.org/10.1155/2014/359494
Research Article

Novel Design Strategy for Checkpoint Kinase 2 Inhibitors Using Pharmacophore Modeling, Combinatorial Fusion, and Virtual Screening

1Department of Computer Science and Information Engineering, Chang Gung University, Taoyuan 33302, Taiwan
2Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan 33302, Taiwan

Received 29 November 2013; Accepted 19 February 2014; Published 23 April 2014

Academic Editor: Che-Lun Hung

Copyright © 2014 Chun-Yuan Lin and Yen-Ling Wang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Culligan, C. E. Robertson, J. Foreman, P. Doerner, and A. B. Britt, “ATR and ATM play both distinct and additive roles in response to ionizing radiation,” Plant Journal, vol. 48, no. 6, pp. 947–961, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Yang, Z.-P. Xu, Y. Huang, H. E. Hamrick, P. J. Duerksen-Hughes, and Y.-N. Yu, “ATM and ATR: sensing DNA damage,” World Journal of Gastroenterology, vol. 10, no. 2, pp. 155–160, 2004. View at Google Scholar · View at Scopus
  3. Q. Liu, S. Guntuku, X.-S. Cui et al., “Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint,” Genes and Development, vol. 14, no. 12, pp. 1448–1459, 2000. View at Google Scholar · View at Scopus
  4. C. Tapia-Alveal, T. M. Calonge, and M. J. O'Connell, “Regulation of Chk1,” Cell Division, vol. 4, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bartek, J. Falck, and J. Lukas, “Chk2 kinase—a busy messenger,” Nature Reviews Molecular Cell Biology, vol. 2, no. 12, pp. 877–886, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Li, B. L. Williams, L. F. Haire et al., “Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2,” Molecular Cell, vol. 9, no. 5, pp. 1045–1054, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. W. Oliver, A. Paul, K. J. Boxall et al., “Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange,” EMBO Journal, vol. 25, no. 13, pp. 3179–3190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Cai, N. H. Chehab, and N. P. Pavletich, “Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase,” Molecular Cell, vol. 35, no. 6, pp. 818–829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. A. Stewart and J. A. Pietenpol, “p53 signaling and cell cycle checkpoints,” Chemical Research in Toxicology, vol. 14, no. 3, pp. 243–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. T. Lountos, A. G. Jobson, J. E. Tropea et al., “Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy,” Journal of Structural Biology, vol. 176, no. 3, pp. 292–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. G. Jobson, G. T. Lountos, P. L. Lorenzi et al., “Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide],” Journal of Pharmacology and Experimental Therapeutics, vol. 331, no. 3, pp. 816–826, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Caldwell, E. J. Welsh, C. Matijssen et al., “Structure-based design of potent and selective 2-(quinazolin-2-yl)phenol inhibitors of checkpoint kinase 2,” Journal of Medicinal Chemistry, vol. 54, no. 2, pp. 580–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G. T. Lountos, A. G. Jobson, J. E. Tropea et al., “X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket,” FEBS Letters, vol. 585, no. 20, pp. 3245–3249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hilton, S. Naud, J. J. Caldwell et al., “Corrigendum to ‘Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2’,” Bioorganic and Medicinal Chemistry, vol. 18, no. 12, p. 4591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. M. Rosen, S. Fan, R. G. Pestell, and I. D. Goldberg, “BRCA1 gene in breast cancer,” Journal of Cellular Physiology, vol. 196, no. 1, pp. 19–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. S. Yang and F. Xia, “BRCA1 16 years later: DNA damage-induced BRCA1 shuttling,” FEBS Journal, vol. 277, no. 15, pp. 3079–3085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Gupta, S. Gupta, H. Dureja, and A. K. Madan, “Superaugmented eccentric distance sum connectivity indices: Novel highly discriminating topological descriptors for QSAR/QSPR,” Chemical Biology and Drug Design, vol. 79, no. 1, pp. 38–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. A. Pasha, M. Muddassar, and S. Joo Cho, “Molecular docking and 3D QSAR studies of Chk2 inhibitors,” Chemical Biology and Drug Design, vol. 73, no. 3, pp. 292–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kubinyi, G. Folkers, and Y. C. Martin, 3D QSAR in Drug Design, Springer, 2002.
  20. Y.-K. Jiang, “Molecular docking and 3D-QSAR studies on β-phenylalanine derivatives as dipeptidyl peptidase IV inhibitors,” Journal of Molecular Modeling, vol. 16, no. 7, pp. 1239–1249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. R. S. Pissurlenkar, M. S. Shaikh, and E. C. Coutinho, “3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment,” Journal of Molecular Modeling, vol. 13, no. 10, pp. 1047–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Sippl, 3D-QSAR—Applications, Recent Advances, and Limitations. Recent Advances in QSAR Studies, Springer, 2010.
  23. A. Lauria, M. Ippolito, M. Fazzari et al., “IKK-β inhibitors: an analysis of drug-receptor interaction by using Molecular Docking and Pharmacophore 3D-QSAR approaches,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 72–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. John, S. Thangapandian, M. Arooj, J. C. Hong, K. D. Kim, and K. W. Lee, “Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors,” BMC Bioinformatics, vol. 12, pp. 1–14, 2011. View at Google Scholar
  25. H. Kubinyi and Comparative Molecular Field Analysis (CoMFA), Handbook of Chemoinformatics: From Data To Knowledge in 4 Volumes, Wiley, 2008.
  26. K. W. Lee and J. M. Briggs, “Comparative molecular field analysis (CoMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods,” Journal of Computer-Aided Molecular Design, vol. 15, no. 1, pp. 41–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Durdagi, T. Mavromoustakos, and M. G. Papadopoulos, “3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 23, pp. 6283–6289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M.-E. Suh, S.-Y. Park, and H.-J. Lee, “Comparison of QSAR methods (CoMFA, CoMSIA, HQSAR) of anticancer 1-N-substituted imidazoquinoline-4,9-dione derivatives,” Bulletin of the Korean Chemical Society, vol. 23, no. 3, pp. 417–422, 2002. View at Google Scholar · View at Scopus
  29. S. J. Bang and S. J. Cho, “Comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) study of mutagen X,” Bulletin of the Korean Chemical Society, vol. 25, no. 10, pp. 1525–1530, 2004. View at Google Scholar · View at Scopus
  30. L. Ghemtio, Y. Zhang, and H. Xhaard, Virtual Screening, InTech, 2012.
  31. G. Klebe, 3D QSAR in Drug Design, vol. 3, Springer, 2002.
  32. G. Klebe and U. Abraham, “Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries,” Journal of Computer-Aided Molecular Design, vol. 13, no. 1, pp. 1–10, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Mitra, A. Saha, and K. Roy, “Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers,” Journal of Molecular Modeling, vol. 16, no. 10, pp. 1585–1596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Boppana, P. K. Dubey, S. A. R. P. Jagarlapudi, S. Vadivelan, and G. Rambabu, “Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models,” European Journal of Medicinal Chemistry, vol. 44, no. 9, pp. 3584–3590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Chopra, R. Gupta, S. Gupta, and D. Saluja, “Molecular modeling study on chemically diverse series of cyclooxygenase-2 selective inhibitors: generation of predictive pharmacophore model using Catalyst,” Journal of Molecular Modeling, vol. 14, no. 11, pp. 1087–1099, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Gaulton, L. J. Bellis, A. P. Bento et al., “ChEMBL: a large-scale bioactivity database for drug discovery,” Nucleic Acids Research, vol. 40, pp. D1100–D1107, 2012. View at Publisher · View at Google Scholar
  37. K. C. Shih, C. W. Shiau, T. S. Chen et al., “Automated chemical hypothesis generation and database searching with Catalyst,” Perspectives in Drug Discovery and Design, vol. 3, pp. 1–20, 1995. View at Google Scholar
  38. D. F. Hsu and I. Taksa, “Comparing rank and score combination methods for data fusion in information retrieval,” Information Retrieval, vol. 8, no. 3, pp. 449–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. C. Vogt and G. W. Cotrell, “Fusion via a linear combination of scores,” Information Retrieval, vol. 1, no. 3, pp. 151–172, 1999. View at Publisher · View at Google Scholar
  40. L. Xu, A. Krzyzak, and C. Y. Suen, “Methods of combining multiple classifiers and their applications to handwriting recognition,” IEEE Transactions on Systems, Man and Cybernetics, vol. 22, no. 3, pp. 418–435, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. J.-M. Yang, Y.-F. Chen, T.-W. Shen, B. S. Kristal, and D. F. Hsu, “Consensus scoring criteria for improving enrichment in virtual screening,” Journal of Chemical Information and Modeling, vol. 45, no. 4, pp. 1134–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Kuriakose, W. T. Chen, Z. M. He et al., “Selection and validation of differentially expressed genes in head and neck cancer,” Cellular and Molecular Life Sciences, vol. 61, no. 11, pp. 1372–1383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. K.-L. Lin, C.-Y. Lin, C.-D. Huang et al., “Feature selection and combination criteria for improving accuracy in protein structure prediction,” IEEE Transactions on Nanobioscience, vol. 6, no. 2, pp. 186–196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. G. T. Lountos, J. E. Tropea, D. Zhang et al., “Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor,” Protein Science, vol. 18, no. 1, pp. 92–100, 2009. View at Publisher · View at Google Scholar · View at Scopus